Pelvic Health

Evvy Expands into Treatment with New Prescription Product Line for Vaginal Health

Evvy, known for its pioneering work in vaginal microbiome testing, today announced its expansion into treatments with a new line of prescription-grade products for vaginal symptom relief. The launch marks a significant milestone for the female-founded startup, as it’s the first time patients can access Evvy’s prescription products without first taking their vaginal microbiome test. The new product line includes prescription-grade suppositories…

Caldera Medical Acquires UVision360 to Expand Hysteroscopy Portfolio

Caldera Medical has announced the acquisition of UVision360, developer of the LUMINELLE hysteroscopy and cystoscopy systems. The deal expands Caldera’s portfolio in minimally invasive solutions for diagnosing and treating conditions such as polyps, fibroids, and intrauterine pathology. “We are excited to integrate LUMINELLE’s technology into Caldera Medical’s growing portfolio,” said Bryon Merade, CEO of Caldera Medical. “This acquisition strengthens our commitment to…

New Study Shows Promise for EnPlace Minimally Invasive Pelvic Organ Prolapse Treatment

A new study published in the “Journal of Clinical Medicine” demonstrates positive outcomes for treating pelvic organ prolapse (POP) using EnPlace, a minimally invasive device for sacrospinous ligament fixation. The research, which included 331 patients, specifically highlights the treatment’s effectiveness in women aged 65 and older. The study divided patients into two age groups: older patients with a mean age of 71.8…

Peer-Reviewed Study Confirms Accuracy of Evvy’s Vaginal Microbiome Test

Evvy, a female-founded biotech startup, has published peer-reviewed validation for its Vaginal Health Test and presented new findings at multiple clinical conferences. The validation study, published in the Diagnostics journal, analyzed over 7,000 vaginal microbiome samples using Evvy’s CLIA, CAP, and CLEP-certified Vaginal Health Test. The results demonstrated a sensitivity of 93.1 percent and specificity of 90 percent across more than 700…

Hologic to Acquire Gynesonics for $350 Million; Expanding Fibroid Treatment Options

Hologic, a medtech company focused on women’s health, has announced a definitive agreement to acquire Gynesonics, a privately held medical device company. The acquisition is valued at approximately $350 million, subject to working capital and other customary closing adjustments. Gynesonics is known for developing the Sonata System, designed for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, including those…

Axena Health’s Leva System Included in NIH-Funded Clinical Trial for Postpartum Urinary Incontinence Treatment

Axena Health, a medical device company specializing in female pelvic health, has announced that its Leva Pelvic Health System will be included in a significant clinical study funded by the National Institutes of Health’s (NIH) Pelvic Floor Disorders Network (PFDN). The study, titled “Training for Urinary Leakage Improvement after Pregnancy” (TULIP), aims to compare three first-line treatments for postpartum urinary incontinence (UI).…

Hyivy Health Secures $2M in Seed Funding to Bring Smart Pelvic Health Device to Market

In the world of women’s health, few areas have been as overlooked and underserved as pelvic health. For decades, patients suffering from chronic pelvic pain and related conditions have faced outdated treatments, limited options, and a lack of understanding from the medical community. Enter Hyivy Health, a Canadian startup that’s not just disrupting the status quo – it’s completely redefining how we…

Comprehensive Human Endometrial Map Provides New Insights into Women’s Health

A detailed map of the human endometrium, the inner lining of the uterus, has recently been released, offering new insights into the cellular processes that occur throughout the menstrual cycle. This research, which covers multiple phases of the cycle, has potential implications for understanding and treating conditions like endometriosis. The study, published in Nature Genetics, is part of the Human Cell Atlas…